Adage Capital Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $94.6M | Buy |
|
|||||
|
2024
Q2 | $108M | Sell |
|
|||||
|
2024
Q1 | $105M | Buy |
|
|||||
|
2023
Q4 | $84.2M | Sell |
|
|||||
|
2023
Q3 | $124M | Buy |
|
|||||
|
2023
Q2 | $93.3M | Buy |
|
|||||
|
2023
Q1 | $41M | Sell |
|
|||||
|
2022
Q4 | $47.9M | Sell |
|
|||||
|
2022
Q3 | $38.7M | Sell |
|
|||||
|
2022
Q2 | $55.6M | Sell |
|
|||||
|
2022
Q1 | $62.1M | Buy |
|
|||||
|
2021
Q4 | $58.8M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $6.94M | Sell |
|
|||||
|
2020
Q2 | $13.1M | Sell |
|
|||||
|
2020
Q1 | $24.1M | Sell |
|
|||||
|
2019
Q4 | $46.3M | Sell |
|
|||||
|
2019
Q3 | $56.9M | Sell |
|
|||||
|
2019
Q2 | $81.7M | Buy |
|
|||||
|
2019
Q1 | $36.1M | Sell |
|
|||||
|
2018
Q4 | $39.9M | Buy |
|
|||||
|
2018
Q3 | $23.6M | Buy |
|
|||||
|
2018
Q2 | $13.8M | Sell |
|
|||||
|
2018
Q1 | $24.6M | Sell |
|
|||||
|
2017
Q4 | $37.6M | Sell |
|
|||||
|
2017
Q3 | $38.5M | Buy |
|
|||||
|
2017
Q2 | $30M | Buy |
|
|||||
|
2017
Q1 | $3.43M | Buy |
|